Publication | Closed Access

Concurrent chemoradiotherapy using cisplatin plus s-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: A single-center feasibility study

Oral FluoropyrimidineConcurrent ChemoradiotherapySurgical OncologyRadiation TherapyMedicineSurgeryCancer TreatmentSingle-center Feasibility StudyOncologyRadiation OncologyLung CancerRadiologyHealth Sciences